Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S0GM
|
||||
Former ID |
DIB006484
|
||||
Drug Name |
ADX-10061
|
||||
Synonyms |
CEE-310; NNC-687; NO-687; CEE-03-310; NNC-01-0687; NNC-01-687
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Discontinued in Phase 2 | [544910] | ||
Company |
Addex Pharmaceuticals; Novo Nordisk A/S
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1([N+](=O)[O-])cc2c([C@@H](c3c4OCCc4ccc3)CN(CC2)C)cc1O
|
||||
CAS Number |
CAS 128022-68-4
|
||||
Target and Pathway | |||||
Target(s) | Dopamine D1 receptor | Target Info | Antagonist | [544911] | |
PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.